Monday, Dec 18, 2017
engineered enzymes for better healthcare
  • Scientist with over 25 years of general management experience in the Healthcare industry and particularly in Diagnostics
  • Non Executive Director and Former Chief Operating Officer with Trinity Biotech Plc
  • Chief Executive Officer of Biosensia Ltd. an Irish based Microfluidics Company specialising in the area of Point of Care Diagnostics
  • Former Managing Director of Cambridge Diagnostics Ltd. a wholly owned subsidiary of Inverness Medical Innovations Inc
  • Non Executive Director of PuriCore Plc. a US based healthcare company
  • Non-Executive Director with a number of early stage biotechnology companies

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...